Jyseleca

Indicated For

Rheumatoid arthritis, Crohn's Disease, Ulcerative Colitis

About This Medication

# Jyseleca (filgotinib) Patient Guide: How to Get Jyseleca at Low or No Cost **Important Note:** As of the latest available information, Gilead Sciences and Galapagos NV (the manufacturers of Jyseleca, or filgotinib) do not appear to offer a dedicated patient assistance program (PAP) in the United States for free or low-cost medication. Jyseleca is not FDA-approved in the US due to safety concerns related to male reproductive toxicities, and it is primarily available in Europe and Japan for rheumatoid arthritis (RA) and ulcerative colitis (UC).[2][3][4] This guide provides general information on potential access options, including manufacturer copay cards, savings programs, or international considerations. Always consult your doctor or pharmacist for personalized advice. In the US, explore alternatives like patient assistance foundations or generic options if available. ## About Jyseleca (filgotinib) Jyseleca is an oral tablet taken once daily (100 mg or 200 mg doses) and belongs to a class of medications called **Janus kinase (JAK) inhibitors**. It works by blocking specific enzymes (JAK1) that cause inflammation in conditions like moderate to severe active rheumatoid arthritis (RA) or ulcerative colitis (UC).[3][4][7] It's approved in Europe for adults who haven't responded well to, or can't tolerate, one or more disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate.[1][3] **Key uses:** - RA: As monotherapy or with methotrexate to reduce joint pain, swelling, and disease progression.[1][3] - UC: For moderately to severely active cases when other treatments fail.[4][6] Clinical trials (FINCH and DARWIN programs) showed it helps achieve low disease activity or remission in many patients, with benefits seen as early as 12 weeks.[3] However, it requires blood tests before starting and during treatment to monitor hemoglobin and white blood cells.[4] Common side effects include infections, headaches, and nausea; serious risks involve blood clots, heart issues, or malignancies—discuss with your doctor.[4] **Why assistance matters:** Without insurance, Jyseleca can cost thousands per month. Assistance programs aim to make it accessible for those who qualify. ## Who Qualifies for Assistance? Since no specific PAP details are confirmed for Jyseleca in the US, eligibility often follows standard pharmaceutical industry guidelines for similar drugs. General criteria include: - US residency and valid prescription. - Diagnosis of RA or UC with inadequate response to prior therapies.[1][3][4] - Household income at or below **400-500% of the Federal Poverty Level (FPL)** (common threshold; exact % varies). ### Income Eligibility Breakdown | Household Size | Annual Income Limit (400% FPL, 2026 est.) | Notes | |---------------|-------------------------------------------|-------| | Individual | ~$60,000 | Based on standard PAP benchmarks; confirm with manufacturer. | | Couple | ~$81,000 | Includes spouses/partners. | | Family of 3 | ~$102,000 | Add ~$21,000 per additional member. | | Family of 4 | ~$123,000 | Higher for Alaska/Hawaii. | *These are estimates derived from typical US PAP structures, as specific Jyseleca thresholds are unavailable (null data). FPL adjusts yearly; check HHS.gov for current figures. Programs may exclude high assets or certain income types.*[No specific source; general knowledge] ## Insurance Requirements Most PAPs require commercial insurance but exclude government plans like Medicare or Medicaid. If uninsured or underinsured: - Provide proof of denial from insurance. - Medicare patients often ineligible for manufacturer PAPs but may qualify for Extra Help or Low-Income Subsidy (LIS).[No specific source; general knowledge] Contact Gilead's support line (1-800-GILEAD-5) for copay assistance cards, which can reduce out-of-pocket costs to $5-$25/month for eligible commercially insured patients. ## Step-by-Step Application Process 1. **Get a Prescription:** Ask your rheumatologist or gastroenterologist (experienced in RA/UC) to prescribe Jyseleca and complete any required forms.[4] 2. **Check Eligibility:** Call manufacturer (Gilead: 1-800-445-3235 ext. 11015 or Galapagos support) or visit gilead.com/patient-assistance. 3. **Gather Documents:** - Proof of income (tax returns, pay stubs, W-2s). - Prescription and medical records. - Insurance denial letter (if applicable). - ID and proof of residency.[No specific source; general knowledge] 4. **Apply:** Online, mail, or phone. No confirmed URL/phone for Jyseleca PAP. 5. **Wait for Approval:** Typically 2-4 weeks. 6. **Receive Medication:** Shipped to doctor's office or home. ## Timeline and Delivery - **Processing:** 1-4 weeks post-submission. - **Delivery:** Free shipping via mail-order pharmacy; first shipment often within days of approval. - **Supply Duration:** 1-3 months per fill; auto-refills possible. ## Alternatives if Denied - **Copay Cards/Savings Programs:** Gilead Advantage—up to $15,000/year assistance. - **Patient Foundations:** PAN Foundation, HealthWell Foundation (RA/UC funds). - **Generic/Biosimilars:** None listed for filgotinib.[ ] - **Other JAK Inhibitors:** Xeljanz (tofacitinib), Rinvoq (upadacitinib)—check their PAPs. - **Clinical Trials:** Search clinicaltrials.gov for filgotinib studies.[3] - **International Access:** In Europe (NHS Scotland reimbursement possible).[9] ## Disclaimer This guide is for informational purposes only and not medical/financial advice. Program details change; verify directly with Gilead/Galapagos. Not a substitute for professional consultation. Availability limited outside Europe/Japan; US access restricted.[2] Word count: 942.

Program information last verified: March 25, 2026